Rowbotham, S. P.
Li, F.
Dost, A. F. M.
Louie, S. M.
Marsh, B. P.
Pessina, P.
Anbarasu, C. R. http://orcid.org/0000-0003-2000-5290
Brainson, C. F.
Tuminello, S. J.
Lieberman, A.
Ryeom, S.
Schlaeger, T. M.
Aronow, B. J.
Watanabe, H.
Wong, K. K.
Kim, C. F.
Article History
Received: 17 August 2018
Accepted: 10 October 2018
First Online: 19 November 2018
Competing interests
: C.F.K. has a sponsored research agreement with Celgene Corporation and has received honorarium from AstraZeneca and MedImmune. K.K.W. is a founder and equity holder of G1 Therapeutics and he has Consulting/Sponsored Research Agreements with AstraZeneca, Janssen, Pfizer, Array, Novartis, Merck, Takeda, Ono, and BMS. S.P.R., A.F.M.D., S.M.L., B.P.M., P.P., C.R.A., C.F.B., S.J.T., H.W., A.L., S.R., B.J.A., F.L., and T.M.S. have no competing interests.